GVAG
REGN icon

Great Valley Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Great Valley Advisor Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Buy
+379
New +$258K ﹤0.01% 928
2025
Q2 		– Sell
-575
Closed -$365K – 933
2025
Q1 		$365K Buy
575
+98
+21% +$67.4K 0.01% 667
2024
Q4 		$340K Buy
477
+35
+8% +$29.4K 0.01% 668
2024
Q3 		$465K Buy
442
+21
+5% +$23.4K 0.01% 580
2024
Q2 		$443K Sell
421
-233
-36% -$226K 0.01% 554
2024
Q1 		$629K Buy
654
+2
+0.3% +$1.9K 0.02% 446
2023
Q4 		$573K Sell
652
-502
-44% -$413K 0.02% 430
2023
Q3 		$950K Buy
1,154
+218
+23% +$171K 0.04% 322
2023
Q2 		$673K Buy
936
+172
+23% +$133K 0.03% 382
2023
Q1 		$628K Buy
+764
New +$576K 0.03% 394
2021
Q4 		– Sell
-543
Closed -$329K – 616
2021
Q3 		$329K Buy
+543
New +$337K 0.02% 444
2020
Q4 		– Sell
-417
Closed -$233K – 481
2020
Q3 		$233K Buy
417
+54
+15% +$32.7K 0.03% 378
2020
Q2 		$227K Buy
+363
New +$206K 0.04% 365

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Great Valley Advisor Group's REGN Position: Q2 2026 in Review

Great Valley Advisor Group opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 379 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #928 among its holdings. This is a return to the name: Great Valley Advisor Group previously reported a position in REGN as recently as Q1 2025.

Great Valley Advisor Group first reported a position in REGN in Q2 2020 and has held it in 13 quarters since. The position peaked at $950K in Q3 2023. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Great Valley Advisor Group held 379 shares of Regeneron Pharmaceuticals worth $236K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Great Valley Advisor Group position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #928 holding.
  • Great Valley Advisor Group first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
  • Great Valley Advisor Group's Regeneron Pharmaceuticals position peaked at $950K in Q3 2023.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.